What Purdue Pharma’s settlement with Oklahoma means for the opioid crisis By Laura Santhanam (March 2019)

‘We owe much to the Sackler family’: How gifts to a top medical school advanced the interests of Purdue Pharma By Andrew Joseph (April 2019)

The chronic-pain quandary: Amid a reckoning over opioids, a doctor crusades for caution in cutting back By Andrew Joseph (May 2019)

‘Game-changer’ - CEO of fentanyl company found guilty of RICO By John Pacenti (May 2019)

Under Pressure From Opioid Lawsuits, One Pain Research Society Considers Bankruptcy By Francie Diep (May 2019)

Getting Pharma Out of Medical Education: An Interview with Dr. Adriane Fugh-Berman By Gavin Crowell-Williamson (June 2019)

US opioid prescribing: the federal government advisers with recent ties to big pharma By Tim Schwab (August 2019)

‘Manipulating physicians’: How drug reps pitch your doc By Laura Hensley and Jane Gerster (August 2019) 

Dr. Fugh-Berman spoke about international promotion of opioids at the International Society of Drug Bulletins at Prescrire's offices in Paris.  (November 2019)

Shining a Light on Drug Industry Influence (December 2019)

Inside the opioid industry’s marketing machine By Sari Horwitz, Scott Higham, Dalton Bennett and Meryl Kornfield (December 2019)

A Drug Company Hiked Up The Price For Its Overdose Antidote By 600% During An Opioid Epidemic By Azeen Ghorayshi (February 2017)

Letter sent to Purdue Pharma, Johnson and Johnson, Insys, Mylan, and Depomed By Senator Claire McCaskill (March 2017)

Trump’s Pick For Drug Czar Hauled In Thousands Of Dollars From Drug Distributors He Wrote Bill To Protect By Josh Keefe (April 2017) 

Lessons From a Professor’s 10-Year Fight to Rein In Pharmaceutical Promotion By Paul Basken (June 2017)

A Drugmaker Tries To Cash In On The Opioid Epidemic, One State Law At A Time By Jake Harper (June 2017)

Why Disclosure Policies Don’t Discourage Academe’s Drug Salesmen By Paul Basken (July 2017)

Amid opioid epidemic, Vivitrol finds success marketing to judges and jailers By Michael Walsh  (July 2017)

To Grow Market Share, A Drugmaker Pitches Its Product To Judges By Jake Harper (August 2017)

Cherry Hill mom: Daughter's opioid death was caused by 'corporate greed' By Don Sapatkin (September 2017)

Christie: Pharma industry to work with NIH on opioid crisis By Jonathan Lai and Don Sapatkin (September 2017)

As he chairs Trump's opioid commission, Christie champions his home-state drug companies By Gregory Korte (October 2017)

Senator Harris Launches Investigation into Pharmaceutical Manufacturer Alkermes Regarding Opioid Addiction Treatment Manipulation By Office of Sen. Kamala D. Harris (November 2017)

Pain Management and the Opioid Crisis By PhRMA and Purdue Pharma (November 2017) 

The Insanity of Taxpayer-Funded Addiction By The New York Times Editorial Board (November 2017)